TapewireFind a company

organization · Reporting owner

A.G.P. / ALLIANCE GLOBAL PARTNERS CORP.

Disclosed activity across 4 companies

Tapewire entity
129409
SEC CIK
0000318492

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Cycurion, Inc.WAVS · Entity 6914UnderwriterJanuary 11, 2022January 11, 2022
Industrial Human Capital, Inc.AXH · Entity 126646UnderwriterOctober 19, 2021October 19, 2021
Mount Rainier Acquisition Corp.RNER · Entity 13471010% ownerOctober 07, 2021October 08, 2021
ZyVersa Therapeutics, Inc.LSPR · Entity 863910% ownerMarch 08, 2022March 08, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Cycurion, Inc.

Report date January 11, 2022 · Filed January 11, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect750,000 Reported balance Holding disclosure · report date 2022-01-11 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 750,000

F1: The securities beneficially owned by the Reporting Person includes 750,000 shares of Common Stock, of which up to 97,826 shares are subject to forfeiture in the event the underwriters of the issuer's initial public offering do not exercise in full their over-allotment option as described in the Registration Statement on Form S-1 (Registration No. 333-260384).

Filing footnotes · ownership attribution and instrument terms

F1: The securities beneficially owned by the Reporting Person includes 750,000 shares of Common Stock, of which up to 97,826 shares are subject to forfeiture in the event the underwriters of the issuer's initial public offering do not exercise in full their over-allotment option as described in the Registration Statement on Form S-1 (Registration No. 333-260384).

Industrial Human Capital, Inc.

Report date October 19, 2021 · Filed October 19, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect750,000 Reported balance Holding disclosure · report date 2021-10-19 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 750,000

F1: The securities beneficially owned by the Reporting Person includes 750,000 shares of Common Stock, of which up to 97,826 shares are subject to forfeiture in the event the underwriters of the issuer's initial public offering do not exercise in full their over-allotment option as described in the Registration Statement on Form S-1 (Registration No. 333-255594).

Filing footnotes · ownership attribution and instrument terms

F1: The securities beneficially owned by the Reporting Person includes 750,000 shares of Common Stock, of which up to 97,826 shares are subject to forfeiture in the event the underwriters of the issuer's initial public offering do not exercise in full their over-allotment option as described in the Registration Statement on Form S-1 (Registration No. 333-255594).

Mount Rainier Acquisition Corp.

Report date October 07, 2021 · Filed October 08, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect865,000 Reported balance After 2021-10-07 transaction · row 1
1 source row

Row 1 · 2021-10-07 · Other · Disposed 50,000 · Balance 865,000

F1: Transfer of shares pursuant to the Underwriting Agreement, and related agreements, including that certain letter agreement (as amended and restated, the "Side Letter"), by and among the Company, DC Rainier SPV LLC ("Sponsor"), and Reporting Person, as representative of the underwriters ("Representative") in the Company's initial public offering ("IPO"). As provided in the Side Letter, upon full exercise of the over-allotment option by underwriters in the IPO, Representative agreed to assign and transfer 50,000 shares of common stock to the Company's Sponsor. Such option was exercised in full concurrently with consummation of the Company's IPO on October 7, 2021.

Filing footnotes · ownership attribution and instrument terms

F1: Transfer of shares pursuant to the Underwriting Agreement, and related agreements, including that certain letter agreement (as amended and restated, the "Side Letter"), by and among the Company, DC Rainier SPV LLC ("Sponsor"), and Reporting Person, as representative of the underwriters ("Representative") in the Company's initial public offering ("IPO"). As provided in the Side Letter, upon full exercise of the over-allotment option by underwriters in the IPO, Representative agreed to assign and transfer 50,000 shares of common stock to the Company's Sponsor. Such option was exercised in full concurrently with consummation of the Company's IPO on October 7, 2021.

ZyVersa Therapeutics, Inc.

Report date March 08, 2022 · Filed March 08, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class B Common StockSEC Table I · non-derivativeDirect446,843 Reported balance After 2022-03-08 transaction · row 1
1 source row

Row 1 · 2022-03-08 · Other · Disposed 3,427 · Balance 446,843

F1: Transfer of shares to certain investors for no consideration as contemplated in connection with Issuer's initial public offering because underwriters' over-allotment option was not fully exercised.

Filing footnotes · ownership attribution and instrument terms

F1: Transfer of shares to certain investors for no consideration as contemplated in connection with Issuer's initial public offering because underwriters' over-allotment option was not fully exercised.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 08, 2022 Filed Mar 8, 2022 13:51 UTC ZyVersa Therapeutics, Inc. LSPR · Entity 8639 OtherClass B Common Stock 3,427 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-016941 · doc4.xml · nonDerivative · entry 1

A.G.P. / ALLIANCE GLOBAL PARTNERS CORP. · CIK 0000318492 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 446,843

F1 · kind: Transfer of shares to certain investors for no consideration as contemplated in connection with Issuer's initial public offering because underwriters' over-allotment option was not fully exercised.

Read SEC document
February 03, 2022 Filed Feb 7, 2022 19:36 UTC ZyVersa Therapeutics, Inc. LSPR · Entity 8639 OtherClass B Common Stock 49,730 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-007614 · doc4.xml · nonDerivative · entry 1

A.G.P. / ALLIANCE GLOBAL PARTNERS CORP. · CIK 0000318492 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,270

F1 · kind: Cancellation of 49,730 shares ("Shares") of Issuer's Class B common stock as contemplated in connection with Issuer's initial public offering. Such Shares were forfeited and cancelled for no consideration because underwriters' over-allotment option was not fully exercised.

Read SEC document
October 07, 2021 Filed Oct 8, 2021 13:44 UTC Mount Rainier Acquisition Corp. RNER · Entity 134710 OtherCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-060015 · doc4.xml · nonDerivative · entry 1

A.G.P. / ALLIANCE GLOBAL PARTNERS CORP. · CIK 0000318492 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 865,000

F1 · kind: Transfer of shares pursuant to the Underwriting Agreement, and related agreements, including that certain letter agreement (as amended and restated, the "Side Letter"), by and among the Company, DC Rainier SPV LLC ("Sponsor"), and Reporting Person, as representative of the underwriters ("Representative") in the Company's initial public offering ("IPO"). As provided in the Side Letter, upon full exercise of the over-allotment option by underwriters in the IPO, Representative agreed to assign and transfer 50,000 shares of common stock to the Company's Sponsor. Such option was exercised in full concurrently with consummation of the Company's IPO on October 7, 2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.